A biotech stock just rocketed 608% after announcing positive phase 3 trial data (MCRB)

Aug 10, 2020

A biotech stock just rocketed 608% after announcing positive phase 3 trial data (MCRB)

Posted by Genevieve Klien in category: biotech/medical

Seres Therapeutics soared as much as 608% on Monday after the company announced positive phase 3 trial data for its drug SER-109 was de…

Leave a reply

GETAS THREAT LEVEL: GUARDED
TOP DONOR: BRIAN CARTMELL
#2 DONOR: DONALD MACLEAN
#3 DONOR: JEFF BONE/TOPSIGHT FUND
#4 DONOR: PEG KAY

LF FUND: $614,817.39
BITCOIN ENDOWMENT: $22,454,310.79
A-PRIZE: $30,015.00
NANOSHIELD: $17,018.00
X-RISKS NETWORK: $3,108.00
AISHIELD: $4,118.00

LIFEBOAT NEWS: 3,200 SUBSCRIBERS
GETAS ALERTS: 571 SUBSCRIBERS
BLOG: 63,315 POSTS
BOARDS: 2,850 MEMBERS
REPORTS: 55
PROGRAMS: 25
FORUMS: 13
QUOTES: 136

FACEBOOK: 11,378 MEMBERS
LINKEDIN: 2,066 MEMBERS
TWITTER FEED: 32,253 MEMBERS
FIGHT AIDS: 3 MEMBERS
[email protected]: 15 MEMBERS
[email protected]: 44 MEMBERS
A-PRIZE: 55 MEMBERS
NANOSHIELD: 69 MEMBERS
AISHIELD: 25 MEMBERS

DONORS: 4,784
LF-500: 13 MEMBERS
PATRON: 1 MEMBER
FIRST CLASS: 1 MEMBER
EXECUTIVE: 12 MEMBERS
ECONOMY: 23 MEMBERS
A-500: 1 MEMBER

© 2002–2021 Lifeboat Foundation